Clinical trial Recruiting at 1 site Interventional Ages 6 to 55

AO-SLO repeatability and cone cell density after repeated low-intensity red-light therapy

Official title: Exploring the Repeatability of Adaptive Optics Scanning Laser Ophthalmoscope Technology (AO-SLO Mona IIa) and the Differences in Cone Cell Density Between Individuals Who Undergone and Not Undergone Repeated Low-level Red-light

Run by Tianjin Medical University Eye Hospital · NCT07160036 · Data updated 2026-11-12

This test will see whether a high-resolution eye imaging device (AO-SLO) gives consistent cone cell density measurements and whether people with myopia aged 6–55 who used repeated low-intensity red-light therapy have different cone density.

Quick facts

Study typeInterventional
Ages6 Years to 55 Years
SexAll
Enrollment180 (estimated)
SponsorTianjin Medical University Eye Hospital
Academic / other
Locations1 site (Tianjin, Tianjin Municipality)
StatusRecruiting
StartedSeptember 20, 2025
Main results expectedNovember 20, 2025
Study endsDecember 20, 2025
Registry record updatedSeptember 15, 2025
Trial IDNCT07160036 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people aged 6–55 with myopia who can attend regular visits and do not have congenital eye disease, prior intraocular surgery, significant strabismus/amblyopia, media opacity, optic nerve disease, or secondary myopia.

Probably not a fit

Patients with secondary myopia, congenital ocular disease, prior intraocular surgery, significant media opacity, abnormal intraocular pressure, optic nerve damage, or those unable to comply with regular visits are unlikely to benefit from participating.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study uses adaptive optics scanning laser ophthalmoscopy (AO-SLO, Mona IIa) to obtain high-resolution images of the cone photoreceptor mosaic and evaluates the repeatability of those measurements. It compares cone cell density between people with myopia who have used repeated low-intensity red-light therapy (RLRL, RS-200-2A) and those who have not, with imaging repeated over time. Participants aged 6–55 who meet ophthalmic inclusion criteria will undergo standardized imaging and clinical exams while investigators monitor ocular safety measures over long-term RLRL exposure. The trial excludes subjects with secondary or congenital eye disease, prior intraocular surgery, significant media opacity, optic nerve pathology, or those unable to attend regular follow-up.

Why it matters

Potential benefit: If successful, this work could validate a reliable imaging method and provide safety data to help clinicians decide whether repeated low-intensity red-light therapy is appropriate for managing myopia.

How similar studies have gone: Previous clinical work has shown repeated low-intensity red-light therapy can slow myopia progression in children, but using AO-SLO to measure cone density and long-term safety data remain relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 6 - 55 years old, gender not limited; Obtained informed consent.

Exclusion Criteria:

* Children with obvious strabismus and amblyopia
* With congenital eye disease, such as congenital cataract, congenital retinal disease
* Secondary myopia (such as premature retinopathy or other eye diseases in infants and children caused secondary myopia), or myopia combined with systemic syndrome (such as Marfan syndrome)
* Had internal eye surgery (such as cataract extraction, intraocular lens implantation, anti-glaucoma surgery, etc.)
* Refractive medium opacity (such as corneal disease, crystal opacity, etc.)
* Bnormal intraocular pressure and clinical significance (IOP \<10 mmHg or IOP\>21mmHg or binocular IOP difference ≥5mmHg)
* Fundus chorioretinopathy (except for high myopia fundus degenerative changes) or other intraocular diseases
* Optic nerve damage or congenital optic nerve dysfunction
* Can not be regularly checked
* The adjustment range is less than 8D or obvious near difficulties
* Other reasons researchers think it is not suitable for inclusion in researchers

Where it's running

  • Tianjin Medical University Eye Hospital
    Tianjin, Tianjin Municipality, China
    Recruiting

Study contacts

  • Principal investigator: Ruihua Wei — Tianjin Medical University Eye Hospital, Tianjin, Tianjin 120120 Recruiting
  • Study coordinator: Guihua Liu
  • Email: liuguihua1992@163.com
  • Phone: +8686428756

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.